特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ライフサイエンス分析の世界市場 - 成長、動向、予測(2019年~2024年)

Life Sciences Analytics Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 708576
出版日 ページ情報 英文 115 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
ライフサイエンス分析の世界市場 - 成長、動向、予測(2019年~2024年) Life Sciences Analytics Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年09月01日 ページ情報: 英文 115 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

世界のライフサイエンス分析市場は、医薬品および臨床試験向け分析ソリューションの採用増加、医療費支出の削減に対する圧力の高まり、患者転帰の改善の必要性、先進分析技術の台頭などによって成長が促進されています。

当レポートでは、世界のライフサイエンス分析市場を調査し、市場の概要、製品タイプ・用途・コンポーネント・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場の成長要因
    • 医薬品および臨床試験における分析ソリューションの採用増加
    • 医療費を削減するための圧力の高まりと患者転帰の改善の必要性
    • ライフサイエンス企業における先進分析技術の登場
  • 市場の阻害要因
    • 熟練人材の不足
    • 実装コストの高さ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第5章 市場セグメンテーション

  • 製品タイプ別
    • 記述的分析
    • 予測的分析
    • 処方的分析
  • 用途別
    • 研究開発
    • サプライチェーン分析
    • セールス・マーケティング
    • その他
  • コンポーネント別
    • サービス
    • ソフトウェア
  • エンドユーザー別
    • 臨床研究機関
    • 製薬・バイオテクノロジー企業
    • 医療機器メーカー
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Accenture
    • Cognizant
    • IBM Corporation
    • MaxisIT Inc.
    • Oracle Corporation
    • IQVIA
    • SAS Institute Inc.
    • SCIOInspire, Corp.
    • TAKE Solutions Limited
    • Wipro Limited

第7章 市場機会および将来動向

目次
Product Code: 62770

Market Overview

The major factors for the growth of the life sciences analytics market include the rising adoption of analytics solutions in pharmaceuticals and clinical trials, growing pressure to reduce healthcare spending, need for improved patient outcomes, and the emergence of advanced analytics method in life science companies.

There is a rise in the use of analytics in clinical trials, as conducting clinical trials has become complex, as it involves many activities and generates high volumes of data from different systems. With the changing regulatory protocol requirements for clinical trial conduction and challenge in data collection, analyzing and preparing a report quickly for submission to the health authority, the adoption of analytics of clinical trials is on the rise.

Analytics may help in optimizing the drug discovery, improve the efficiency of clinical trials. With huge data generated from the R&D process and clinical research, pharma companies can identify potential drug candidates with a high probability of successfully developing into drugs. Most contract research organizations (CROs) with established systems for data capture, advanced analytics are now incorporated, across all systems, such as drug discovery, clinical development, which are providing real-time analysis and creating alerts to each divisions concerning safety or efficacy. Application of analytics in evaluating a potential drug candidate for clinical development may reduce the time and R&D expenditure. Eli Lilly's has developed phenotypic drug discovery platform, where researchers can screen their compounds without giving intellectual property. All the above may increase the application of analytics in life science and related companies, and thereby, lead to the growth of the market studied.

Scope of the Report

As per the scope of this report, the term life science analytics refers to any analytical applications that are used in clinical research organizations, pharmaceutical medical device companies, and its various divisions, such as research, supply chain, marketing, pharmacovigilance, and others.

Key Market Trends

Clinical Research Institutions is Expected to witness the Fastest Growth over the Forecast Period.

Analytics in clinical research helps the pharmaceutical companies to analyze the data for comparison of ongoing trials at different sites and populations, preparation of reports for submission to the regulatory authority and get approval. Analytics in clinical trials is useful in understanding the outcome of the trial at each phase (Phase I, II, III, IV). This becomes a decision factor situations, such as whether to go forward with the trial or stop the trial, submission of the clinical data report as required by regulatory authorities at the earliest, and prevention of delay of regulatory approval. In today's time where there is high competition from other major companies, analytics could be much helpful to mitigate some of the challenges. Automation of clinical research data is also expected to greatly bring down the number of problems in large clinical trials.

North America is Expected to Dominate the Market

The life science and pharmaceutical industry are facing challenges related to R&D and regulatory changes. The introduction of the Affordable Care Act (ACA) in the United States is changing the regulatory framework, increased scrutiny, reimbursement based on the health outcomes. To tackle the challenges, most companies in the United States are implementing analytics on their own or using third party analytics services for support. Analytics solutions are creating an impact that are providing simple reporting solutions to descriptive and predictive analytic solutions. The companies based in the United States are adopting new analytics solutions in their business that include: analysis of clinical research data from SAS database is helpful in early-stage drug development, analyzing adverse event incidence and reporting in clinical trials, revenue forecasting and prediction of health outcomes. With Life science and Pharmaceutical companies leveraging the support from third-party solution providers, in clinical development, trial planning, cohort building, market analytics, and patient analytics, the US life science analytics market is expected to witness high growth, over the forecast period.

Competitive Landscape

The market studied is a fragmented market owing to the presence of various market players. Some of the market players are Accenture, Cognizant, IBM Corporation, MaxisIT Inc., Oracle Corporation, IQVIA, SAS Institute Inc., SCIOInspire, Corp., TAKE Solutions Limited, and Wipro Limited.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Adoption of Analytics Solutions in Pharmaceuticals and Clinical Trials
    • 4.2.2 Growing Pressure to Reduce Healthcare Spending and the Need for Improved Patient Outcomes
    • 4.2.3 Emergence of Advanced Analytics Method in Life Science Companies
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Personnel
    • 4.3.2 High Implementation Costs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Descriptive Analytics
    • 5.1.2 Predictive Analytics
    • 5.1.3 Prescriptive Analytics
  • 5.2 By Application
    • 5.2.1 Research and Development
    • 5.2.2 Supply Chain Analytics
    • 5.2.3 Sales and Marketing
    • 5.2.4 Others
  • 5.3 By Component
    • 5.3.1 Services
    • 5.3.2 Software
  • 5.4 By End User
    • 5.4.1 Clinical Research Institutions
    • 5.4.2 Pharmaceutical and Biotechnology Companies
    • 5.4.3 Medical Device Companies
    • 5.4.4 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 US
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 UK
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Accenture
    • 6.1.2 Cognizant
    • 6.1.3 IBM Corporation
    • 6.1.4 MaxisIT Inc.
    • 6.1.5 Oracle Corporation
    • 6.1.6 IQVIA
    • 6.1.7 SAS Institute Inc.
    • 6.1.8 SCIOInspire, Corp.
    • 6.1.9 TAKE Solutions Limited
    • 6.1.10 Wipro Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS